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delay dependence. Few studies have explored such a relationship in Continental 
Europe. Methods: We use data from the DEP-FR study. We ran ordered logisitic and 
heckman regressions. Results: We provide evidence: that there is a positive and 
significant correlation between cognitive, functional and behavioral declines and 
dependence on others, that an increase in dependence on others is associated with 
a decrease in informal care providers’ satisfaction, that there is a linear relationship 
between dependence on others and informal and formal care use. ConClusions: 
Our results provide two main dependence policies perspectives. First, public inter-
ventions should try to reduce dependence through its three main dimensions of 
dependence on others (cognitive, behavioral and functional), and not only focus 
on the functional dimension of dependence. Second, specific measures should be 
implemented to the release of informal caregivers’ burden, which increases with 
dependence on others.
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objeCtives: The prevalence and economic burden of dementia is increasing, and 
in 2007 the UK government declared dementia a national priority. This research 
aims to evaluate trends in care home costs for dementia patients following this 
announcement, and to discuss the implications for the future economic burden 
of dementia. Methods: PubMed was searched for terms related to ‘cost’, ‘care 
homes’ and ‘dementia’. Horizon scanning was additionally performed for costs 
of care home data in the context of the wider economic burden of dementia. Only 
UK studies published after 2007 were considered, and information from a range of 
sources was assimilated to understand future implications for the economic burden 
of dementia. Results: Four relevant PubMed articles and an additional twelve 
publications from horizon scanning were identified. It was reported that two-thirds 
of care home patients have dementia and that accommodation costs represent the 
major contributor to the cost of dementia (41%). The average annual cost of a care 
room had risen from £25,953 in 2011 to £27,404 in 2012 and this was accompanied 
by a 3.9% deficit in local authority payment increases for care home residents from 
2010 to 2012. It is estimated that by 2043, more than double the current number of 
care home places will be required to match the increase in dementia prevalence, 
and the economic dependency ratio is expected to increase from 24% to 30% over 
the next 15 years. ConClusions: A considerable proportion of dementia patients 
are treated in care homes and, considering the disparity between the rising costs of 
care homes and funding increases, the burden borne by patients and their families 
is increasing. There is therefore an imminent need to develop cost-effective service 
provision for dementia patients; the new remit of NICE in social care may represent 
an important step towards this.
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objeCtives: Management of chronic nonmalignant pain (CNMP) is important in 
both primary care and rehabilitative medicine however, the relationships between 
CNMP and the diverse types of addiction and chemical dependency are often 
complex and clinically relevant. The objective of this pilot study was to examine 
the impact of the Functional Restoration and Pain Management (FRPM) Program 
on pain severity outcomes and controlled medication use among CNMP patients 
enrolled in the Texas Workers Compensation (TWC) benefit program. Methods: 
A retrospective cohort analysis of administrative claims and medical records data 
was conducted among TWC chronic pain patients enrolled in the FRPM Program 
receiving buprenorphine therapy. Prescription utilization patterns and pain severity 
outcomes during a 12-month observation period were examined. Eligible patients 
were ≥ 18 years of age, continuously enrolled as TWC beneficiaries, had a history 
of utilization of chronic pain medications at enrollment, placed on buprenorphine 
therapy, and received services through the FRPM program within the observation 
period defined as date from patient entry into the program to 12 months post-
enrollment. Results: The mean age of eligible participants (N= 18) enrolled in the 
pilot study was 49.6 years ±9.5. A majority of patients were male (61%), white (61%), 
had a chronic pain lumbar diagnosis (45%), depression comorbidity (78%), and a 
substance abuse disorder (39%). Overall, patients showed a significant reduction in 
pain scores (p= 0.032) at month 12 compared to baseline. For controlled medication 
utilization, there was a significant difference in narcotic pain medication use reduc-
tion in Hispanics/Latinos (p= 0.033) compared to other racial/ethnic groups (i.e., 
Whites and African-Americans) at month 12 compared to baseline. ConClusions: 
Though a pilot study, the results suggest that the FRPM program has the potential 
of improving health outcomes of patients with chronic pain, while reducing their 
use of controlled medications. A larger follow-up study is needed to validate and 
expand on these preliminary findings.
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objeCtives: To examine caregiver reported impact of ASD on family as compared 
to impact of other developmental disabilities (DD) and mental health conditions 
(MHC) on family. Methods: A cross-sectional study using 2009-2010 National 
Survey of Children with Special Health Care Needs on caregivers of children aged 
3-17 years with either ASD, DD, MHC, or both DD and MHC diagnosis (N = 18,136) 
infrequent (4% diabetes and 3% neurological disorders). The most common depot 
antipsychotics prescribed were zuclopentixol (32%), perphenazine (28%) and risp-
eridone LAI (19%). These were prescribed primarily by psychiatrists (85%). Median 
persistence to depot treatment was 195 days. ConClusions: To our knowledge, 
this is the first large database study conducted in Sweden aiming at describing 
the patients’ characteristics and treatment patterns of schizophrenic patients 
treated with depot antipsychotics. It is notable that the current sub-population of 
schizophrenic patients treated with depot does not show substantial psychiatric 
and somatic co-morbidities, possibly due to under-diagnosing of co-morbidities, 
especially somatic diseases, by psychiatrists.
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objeCtives: To examine the economic burden and health care utilizations of 
schizophrenia in the U.S. veteran population. Methods: A retrospective database 
analysis was performed using the Veterans Health Administration (VHA) Medical 
SAS datasets from October 1, 2008 to September 30, 2012. Patients diagnosed with 
schizophrenia were identified using International Classification of Disease 9thRevi-
sion Clinical Modification (ICD-9-CM) diagnosis codes 295.xx, and the first diagnosis 
date was designated as the index date. A group of patients without schizophrenia 
of the same age, region, gender and index year were identified and matched by 
baseline Charlson Comorbidity Index (CCI) as the comparison group. Patients in 
both groups were required to be at least 18 years old and have continuous medical 
and pharmacy benefits 1 year pre- and 1 year post-index date. One-to-one propen-
sity score matching was used to compare health care costs and utilizations during 
the follow-up period between the schizophrenia and comparison group patients, 
adjusted for baseline demographic and clinical characteristics. Results: A total of 
171,086 eligible patients were identified for the schizophrenia and control cohorts. 
After 1:1 matching, a total of 70,045 patients were matched from each cohort with 
well-balanced baseline characteristics. Patients diagnosed with schizophrenia had 
significantly higher health care utilization in inpatient (18.12% vs. 2.30%, p< 0.01), 
emergency room (19.67% vs. 6.46%, p< 0.01), office (98.32% vs. 53.26%, p< 0.01), and 
outpatient visits (98.53% vs. 54.16%, p< 0.01). Higher health care utilizations trans-
lated into higher costs for schizophrenic patients including inpatient ($7,228 vs. 
$613, p< 0.01), pharmacy ($1,012 vs. $343, p< 0.01), outpatient ($3,998 vs. $1,302, 
p< 0.01), and total costs ($12,238 vs. $2,260, p< 0.01) relative to patients in the com-
parison group. ConClusions: Schizophrenic patients were associated with a sub-
stantial economic burden compared to their matched controls.
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objeCtives: To compare health care resource utilization (HRU) among schizo-
phrenic patients in the United States by the type of health insurance and estimate 
the annual expenditures. Methods: The 2007 National Health and Interview 
Survey (NHIS) data were used for this study (150 schizophrenia cases). Multivariate 
regression was conducted to compare HRU (hospitalizations, physician visits, ER vis-
its) by type of health of insurance (any private, public only, and none). Additionally, 
2008 Medical Expenditure Panel Survey (MEPS) data were linked with the NHIS data 
(29 of the NHIS cases). Means, SE and 95% confidence intervals of prescription and 
total health care annual expenditures were calculated for schizophrenic patients 
by insurance type. Results: Multivariate analysis indicated a significant associa-
tion between the number of hospitalizations, physician visits and ER visits over 
12 months and any private insurance (β = -2.06, SE= 0.84, p= 0.01; -19.69, 8.92, 0.03; 
-22.35, 9.55, 0.02, respectively) compared to no insurance (referent). These same 
associations were not significant for the public only insurance (-0.30, 0.44, 0.16; 
-5.89, 3.91, 0.13; -7.72, 4.09, 0.06, respectively). Mean, SE [95% confidence interval] 
prescription expenditures for schizophrenic patients are similar between private 
insurance holders ($737, 215.3 [312.3-1161.6]) and those without insurance ($718, 
237.0 [249.7-1186.3]), but were higher for public insurance holders ($3781, 897.2 
[2008.1-5553.0]). Mean total health care expenditures for schizophrenic patients are 
similar between private insurance holders ($4000, 1382.4 [1273.9-6726.7]) and those 
without insurance ($4318, 2215.4 [0-8696.6]), but were higher for public insurance 
holders ($12,584, 2452.2 [7739.6-17,428.8]). ConClusions: Private insurance HRU 
for schizophrenic patients is lower than public only insurance holders, followed 
by those without insurance. Seemingly contradictory, a higher expenditure among 
public insurance holders was observed. This observation could be the result of the 
more severe schizophrenic cases having only public insurance. Caution should be 
employed in the use of the expenditure calculations due to the small numbers of 
patients.
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objeCtives: The increasing economic importance of dependence on others in the 
elderly population is a major problem in Europe. This problem is very concern-
ing for patients with Alzheimer’s disease, who heavily rely on informal caregivers’ 
assistance. Exploring the relationship between patients’ dependence on others 
and care expenditures is very important when planning future resources for the 
elderly and for predicting the economic consequences of interventions which may 
